FOR IMMEDIATE RELEASE
July 12, 2024

The Georgia Department of Public Health (DPH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) are investigating reports of severe illnesses associated with Diamond Shruumz-brand chocolate bars, cones, and gummies.

Diamond Shruumz products may contain harmful and undisclosed ingredients, including psychoactive compounds that can cause serious illness when eaten. These “edibles” are often sold as gummy candies, chocolates, or other snack foods that frequently appeal to children and teenagers.

The Diamond-Shruumz-brand products are sold online and at retailers nationwide. They are commonly available at consumable hemp retailers and tobacco and vape shops. The products have been recalled but may still be available for sale in some places. Retailers should remove products from their shelves and consumers should discard any products that have been purchased.

As of July 8, 2024, 58 illnesses have been reported in 27 states, including several reports in Georgia that are being investigated. Of the people who became ill after eating these products, more than half were hospitalized, and there is one potentially associated death under investigation. The investigation is ongoing to identify other cases.

People who became ill from Diamond Shruumz-brand products reported a variety of severe symptoms, including hallucinations, uncontrolled movements, fast or slow heart rate, high or low blood pressure, flushed skin, and gastrointestinal effects (such as nausea, vomiting, or abdominal pain). Other severe adverse effects have been reported, including seizures, decreased level of consciousness, loss of consciousness, confusion, sleepiness, and respiratory failure.

If you have consumed any Diamond Shruumz products and are experiencing symptoms, seek immediate medical attention or call the Georgia Poison Center at 1-800-222-1222. Healthcare providers should also report illnesses to the Georgia Poison Center at 1-800-222-1222.

The investigation into these illnesses is ongoing. For more information, visit the FDA or CDC websites.